Determining the appropriate time of execution of an I-131 post-therapy whole-body scan
- 1 September 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Nuclear Medicine Communications
- Vol. 34 (9), 900-908
- https://doi.org/10.1097/mnm.0b013e328363cc5c
Abstract
The aim of this study was to investigate the appropriate time for performing an iodine-131 post-therapy whole-body scan (TxWBS) through a qualitative and semiquantitative analysis of early and late scans. This study evaluated pairs of scans of 134 patients who underwent TxWBS on the third and seventh day. The scans were analyzed to evaluate sites, intensity of uptake, concordance or discordance between the scans, relationship with risk factors, and serum thyroglobulin (Tg) levels. To evaluate early and late radioiodine kinetics in thyroid remnants and metastases, 65/134 pairs of scans (48.5%) were subjected to a semiquantitative analysis. The early and late scans furnished concordant images in 108/134 patients (80.5%). In 10/134 patients (7.5%), early scans provided more information compared with late scans, showing lymph node and distant metastases in seven and three patients, respectively. In 16/134 patients (12%), late scans provided more data compared with early scans, with thyroid remnants and lymph node and distant metastases demonstrated in four, seven, and five patients, respectively. Negative early/positive late TxWBS results in patients were found to be significantly correlated (P=0.007) with elevated serum levels of Tg and a high-risk for recurrence (P=0.003). This study suggests that in about 20% of patients early or late TxWBS can miss the visualization of thyroid remnants or lymph node or distant metastases, which can be achieved performing both studies. High-risk patients with elevated serum Tg levels should be considered for a late TxWBS, which can demonstrate a possible metastatic involvement that was not diagnosed or that was downstaged by early TxWBS.Keywords
This publication has 11 references indexed in Scilit:
- The Utility of I-123 Pretherapy Scan in I-131 Radioiodine Therapy for Thyroid CancerThyroid®, 2012
- The comparison of 131I whole-body scans on the third and tenth day after 131I therapy in patients with well-differentiated thyroid cancer: preliminary reportAnnals of Nuclear Medicine, 2011
- Staging of Differentiated Thyroid Carcinoma Using Diagnostic 131I SPECT/CTAmerican Journal of Roentgenology, 2010
- Appropriate Time for Post-Therapeutic I-131 Whole Body ScanClinical Nuclear Medicine, 2009
- Initial Staging of Differentiated Thyroid Carcinoma: Continued Utility of Posttherapy131I Whole-Body ScintigraphyRadiology, 2008
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumActa Endocrinologica, 2006
- Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinomaJournal of Clinical Endocrinology & Metabolism, 1994
- Value of Post-Therapy Whole-Body I-131 Imaging in the Evaluation of Patients with Thyroid Carcinoma Having Undergone High-Dose I-131 TherapyClinical Nuclear Medicine, 1989
- Prognostic value of the131I whole-body scan in postsurgical therapy for differentiated thyroid cancerCancer, 1983
- Value of Thyroid Carcinoma Imaging After Therapeutic Doses of RadioiodineClinical Nuclear Medicine, 1981